Insmed Inc (INSM)
70.59
+0.15
(+0.21%)
USD |
NASDAQ |
Dec 23, 16:00
70.58
-0.01
(-0.01%)
Pre-Market: 20:00
Insmed Shareholders Equity (Quarterly): 483.42M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 32.35M |
| Cytokinetics Inc | -13.91M |
| Amicus Therapeutics Inc | 178.82M |
| Collegium Pharmaceutical Inc | 234.28M |
| Krystal Biotech Inc | 885.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.053B |
| Total Liabilities (Quarterly) | 1.570B |
| Debt to Equity Ratio | 1.975 |
| Current Ratio | 6.365 |
| Net Debt Paydown Yield | 0.28% |